FFAR3 (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:2865, FFA3R, FFAR3, GPR41, GPR42, HGNC:4499, MIM:603821, NM_005304, NP_005295, XM_011526858, XP_011525160, free fatty acid receptor 3

Id:ENSG00000185897

Entrez:2865

Ensembl:ENSG00000185897

Description:free fatty acid receptor 3

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View FFAR3's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with FFAR3.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using FFAR3.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for FFAR3.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with FFAR3.

Results found

Linked to

	Label	Description
	GSE110709 GSK-J4 5 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119424 GSE120214 TBXT brachyury inhibition 7 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119424 GSE120214 TBXT brachyury inhibition 1 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273 GSE216292 palbociclib 0 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE245677 CDK2 inhibition 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE265849 MrgD overexpression muscle organ 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119424 GSE120214 TBXT brachyury inhibition 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE164874 prednisolone muscle organ 5 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE157594 0 V 7 NICOTINAMIDE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE182150 KIT LSD1 MYC inhibition 6 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE110709 GSK-J4 5 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE119424 GSE120214 TBXT brachyury inhibition 7 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE119424 GSE120214 TBXT brachyury inhibition 1 v 6 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE216273 GSE216292 palbociclib 0 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE245677 CDK2 inhibition 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE265849 MrgD overexpression muscle organ 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE119424 GSE120214 TBXT brachyury inhibition 1 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE164874 prednisolone muscle organ 5 v 10 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE157594 0 V 7 NICOTINAMIDE MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE182150 KIT LSD1 MYC inhibition 6 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.